tradingkey.logo
tradingkey.logo
Search

Guardian Pharmacy Services Inc

GRDN
Add to Watchlist
39.966USD
-1.924-4.59%
Market hours ETQuotes delayed by 15 min
2.53BMarket Cap
47.21P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-22
Previous score
9.33
Change
0
The current earnings forecast score of Guardian Pharmacy Services Inc is 9.33, ranking 1 out of 30 in the Food & Drug Retailing industry. The average price target is 34.50, with a high of 35.00 and a low of 32.00.

Analyst Rating

Based on 6 analysts
Strong Buy
Current Rating
47.000
Target Price
+10.82%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

5
Total
1
Median
1
Average
Company name
Ratings
Analysts
Guardian Pharmacy Services Inc
GRDN
6
Petmed Express Inc
PETS
1
High Tide Inc
HITI
1
Walgreens Boots Alliance Inc
WBA
0
IM Cannabis Corp
IMCC
0
1

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Guardian Pharmacy Services Inc's expected revenue for the next quarter?

Guardian Pharmacy Services Inc's expected revenue is 340.04M.

What is Guardian Pharmacy Services Inc's price target?

Analysts forecast that Guardian Pharmacy Services Inc's price target is USD 34.50, with the highest forecast at USD 35.00 and the lowest forecast at USD 32.00.

How have Guardian Pharmacy Services IncGRDN's recent earnings per share performed?

The market expectation was USD 0.21, while Guardian Pharmacy Services IncGRDN's earnings per share (EPS) for the previous quarter was USD 0.79. EPS for the next quarter is expected at USD 0.27.

What is the analyst rating for Guardian Pharmacy Services Inc?

Based on the ratings of Guardian Pharmacy Services Inc's stock from 6 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI